S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AXSM Axsome Therapeutics Inc

86.00

0.02 (0.02%)

After Hours

Last Updated: 08:52:08

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics Inc News

Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5
Thursday 11 July 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 12 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 12 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 5 June 2024 (2 months ago) • Edgar (US Regulatory)

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
Wednesday 5 June 2024 (2 months ago) • GlobeNewswire Inc.

Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month
Tuesday 4 June 2024 (2 months ago) • GlobeNewswire Inc.

Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
Monday 3 June 2024 (2 months ago) • GlobeNewswire Inc.

Axsome Therapeutics to Participate in Upcoming Investor Conferences
Thursday 30 May 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 30 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 30 May 2024 (2 months ago) • Edgar (US Regulatory)

More Axsome Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions